According to Future Market Insights (FMI) analysis in a recent market survey, the global mastectomy reconstruction implants market was valued at USD 1.95 Billion in 2022 and is set to reach USD 4.69 Billion by 2033.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 1.95 Billion |
| Market Value 2023 | USD 2.09 Billion |
| Market Value 2033 | USD 4.69 Billion |
| CAGR 2023 to 2033 | 8.4% |
| Share of Top 5 Countries | 60.5% |
| Key Players | Mentor Worldwide LLC (Johnson & Johnson Services; Inc.); AbbVie Inc. (Allergan PLC); Hans Biomed Co.; Ltd; Galderma SA; GC Aesthetics; POLYTECH Health & Aesthetics GmbH; Sientra Inc; PMT Corporation; Ideal Implant Inc; Groupe Sebbin SAS; Hologic; Inc; Guangzhou Wanhe Plastic Materials Co.; Ltd; Establishment Labs S.A; RTI Surgical Holdings Inc; and Nagor Limited |
Mastectomy reconstruction implants are breast implants that are used to reconstruct the breast tissue after a mastectomy, which is a surgical procedure in which one or both breasts are removed due to cancer or other medical conditions. The implants are typically made of silicone or saline and are placed under the chest muscle or breast tissue to create a natural-looking breast shape.
Overall, the increasing incidence of breast cancer, the growing demand for cosmetic surgeries, and the availability of technologically advanced breast implants, will boost the market in the coming years.
For instance, In 12 November 2019, BellaSeno and Evonik collaborated to bring an advanced 3D-printed breast implant technology to market. This technology designed to improve quality of life for patients after breast reconstruction and augmentation.
Sales of the mastectomy reconstruction implants market grew at a CAGR of 6.6% between 2016 and 2022. Mastectomy reconstruction implants market contributes 49.0% revenue share to the global breast reconstruction surgery and treatment market which is valued around USD 3.97 Billion in 2022.
There is a growing demand for breast reconstruction surgeries, and as a result, the demand for mastectomy reconstruction implants is also increasing. This is due to several factors, including rising awareness, improved surgical techniques, and the increasing incidence of breast cancer.
Many healthcare organizations are promoting breast reconstruction surgery and treatment as part of breast cancer care.
There are several manufacturers in the mastectomy reconstruction implants market, and competition is high. As a result, manufacturers are focusing on developing innovative products, improving their distribution networks, and providing excellent customer service to maintain or gain market share. Manufacturers are collaborating with healthcare professionals, research institutions, and other industry players to develop new products and improve existing ones. These collaborations can help manufacturers to stay at the forefront of the market and meet the changing needs of customers.
Considering this, FMI expects the global mastectomy reconstruction implants market to grow at a CAGR of 8.4% through the forecasted years.
Small-sized breast implants are becoming popular among women who desire natural-looking results from their breast reconstruction surgery. These implants can provide a subtle enhancement of breast size and shape without appearing overly artificial. This is driven by the growing awareness of the importance of natural-looking results in the market.
There has been a significant increase in the availability of small-sized breast implants in recent years. This is due to the development of new technologies and materials, as well as advances in surgical techniques. Small-sized breast implants are often used in minimally invasive breast reconstruction procedures, which are becoming increasingly popular.
The trend toward personalized medicine is also reflected in breast reconstruction surgeries. Surgeons are now better able to tailor the procedure to the individual needs of each patient, taking into account factors such as their body shape, breast size, and desired outcome. In many countries, insurance coverage for breast reconstruction surgeries is mandated by law. This has made breast reconstruction more accessible to women who may not have been able to afford the procedure otherwise.
Breast implants are not lifelong, and breast implant surgery carries the risk of complications that may eventually lead to the removal of the breast implants. Commonly observed complications include narrowing of the area around the implant (capsular contracture), additional surgery, and removal of the implant.
The increased risk of serious complications is a significant restraint to the growth of the breast reconstruction surgery and treatment market. Complications such as infection, bleeding, implant rupture or leaks, capsular contracture, and implant malposition can lead to additional surgeries, longer recovery times, and even permanent damage.
In addition to the risk of complications, the cost of breast reconstruction can also be a barrier in the market. The increased risk of serious complications is a significant barrier to the growth of the market. Women considering breast reconstruction surgery should carefully consider the potential risks and benefits and seek advice from a qualified healthcare provider. While mastectomy reconstruction implants are a popular option for breast reconstruction, some patients may opt for other treatments, such as autologous tissue reconstruction, which involves using tissue from the patient's own body to reconstruct the breast.
These factors are expected to hamper the revenue growth of the market over the forecast period.
The USA. dominated the global market in 2022 with a 94.5% value share in the North American market.
Favorable reimbursement policies are one of the key factors that make the USA the dominating country in the market. The Centers for Medicare & Medicaid Services (CMS) in the USA has established reimbursement policies that make breast reconstruction surgery and the use of mastectomy reconstruction implants more accessible and affordable for patients. Medicare, the federal health insurance program for people over 65 and those with certain disabilities covers breast reconstruction surgery and the use of mastectomy reconstruction implants following a mastectomy for breast cancer. Private insurance plans are also required to provide coverage for breast reconstruction surgery under the Women's Health and Cancer Rights Act of 1998.
Favorable reimbursement policies help to ensure that patients have access to mastectomy reconstruction implants and that healthcare providers can provide these services without financial barriers. This has helped to increase the adoption rate of breast reconstruction surgery and the use of mastectomy reconstruction implants in the USA
Germany dominated the Western European market for mastectomy reconstruction implants and accounted for around 26.7% of the market share in 2022.
Breast reconstruction surgery has become more common in Germany due to increased awareness and education about the procedure, as well as advancements in surgical techniques and technology.
Germany also has a strong healthcare system with highly trained medical professionals, making it an attractive destination for medical tourism. Many women from other countries travel to Germany for breast reconstruction surgery, further driving demand for mastectomy reconstruction implants in the country.
Brazil held nearly 49.5% of the Latin America market for mastectomy reconstruction implants.
The market in Brazil is expected to grow significantly in the coming years due to several factors. Brazil has a large population of over 211 million people, and breast cancer is the leading cancer among women in the country.
The direct-to-implant reconstruction segment held the major chunk of about 55.0% of the global market in 2022.
The implant is placed immediately after the mastectomy, the overall breast shape can be more easily controlled and optimized. Direct-to-Implant (DTI) reconstruction allows for the immediate placement of the implant, which means the overall breast shape can be more easily controlled and optimized. The surgeon can better adjust the size, shape, and position of the implant during surgery, resulting in a more natural-looking breast. Patients can see the results immediately after surgery, which can help alleviate anxiety and improve their overall satisfaction with the procedure.
The hospitals segment accounted for a revenue share of 42.2% in the global market in 2022.
Mastectomy reconstruction implant surgery is a complex procedure that requires specialized equipment, facilities, and skilled healthcare professionals. Hospitals are well-equipped to handle such surgeries and have dedicated units and teams that specialize in breast reconstruction procedures. Hospitals are the preferred choice for patients undergoing breast reconstruction surgery due to the perceived safety and quality of care provided. Patients often prefer to undergo surgery in a hospital setting where they can receive specialized care and access to advanced medical technology.
Key players in the market are focused on increase their product portfolio to strengthen their position in the market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and approvals of the products to expand their business.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the mastectomy reconstruction implants market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2016 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan & Baltic Countries; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam, Australia & New Zealand, Germany, France, Spain Italy, BENELUX, Nordic Countries, UK, Poland, Hungary, Romania, Czech Republic, Central Asia, Russia & Belarus, Balkan & Baltic Countries, GCC Countries, Kingdom of Saudi Arabia, Türkiye, Northern Africa, South Africa, Israel |
| Key Segments Covered | Product, End User, and Region |
| Key Companies Profiled | Mentor Worldwide LLC (Johnson & Johnson Services, Inc.); AbbVie Inc. (Allergan PLC); Hans Biomed Co., Ltd; Galderma SA; GC Aesthetics; POLYTECH Health & Aesthetics GmbH; Sintera Inc; PMT Corporation; Ideal Implant Inc; Groupe Sebbin SAS; Hologic, Inc; Guangzhou Wanhe Plastic Materials Co., Ltd; Establishment Labs S.A; RTI Surgical Holdings Inc.; Nagor Limited |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global market value could be around USD 2.09 billion in 2023.
Direct-to-implant reconstruction segment is expected to lead through 2033.
The United States leads the market with a 94.5% share in 2022.
The hospital segment captured an overall market share of 42.2% in the year 2022.
Brazil dominate the market, with a market share of around 49.5%.
Explore Therapeutic Device Insights
Mastectomy Reconstruction Implants Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
